Taisheng Li to Pandemics
This is a "connection" page, showing publications Taisheng Li has written about Pandemics.
Connection Strength
0.058
-
Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia. Emerg Microbes Infect. 2020 Dec; 9(1):727-732.
Score: 0.008
-
Clinical observation and management of COVID-19 patients. Emerg Microbes Infect. 2020 Dec; 9(1):687-690.
Score: 0.008
-
Significance of serology testing to assist timely diagnosis of SARS-CoV-2 infections: implication from a family cluster. Emerg Microbes Infect. 2020 Dec; 9(1):924-927.
Score: 0.008
-
Prolonged presence of viral nucleic acid in clinically recovered COVID-19 patients was not associated with effective infectiousness. Emerg Microbes Infect. 2020 Dec; 9(1):2315-2321.
Score: 0.008
-
High-Dose Intravenous Immunoglobulins in the Treatment of Severe Acute Viral Pneumonia: The Known Mechanisms and Clinical Effects. Front Immunol. 2020; 11:1660.
Score: 0.007
-
COVID-19: towards understanding of pathogenesis. Cell Res. 2020 05; 30(5):367-369.
Score: 0.007
-
Clinical characteristics and survival analysis in critical and non-critical patients with COVID-19 in Wuhan, China: a single-center retrospective case control study. Sci Rep. 2020 10 16; 10(1):17524.
Score: 0.002
-
Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients. J Thromb Thrombolysis. 2020 Oct; 50(3):580-586.
Score: 0.002
-
Clinicopathological Features and Outcomes of Acute Kidney Injury in Critically Ill COVID-19 with Prolonged Disease Course: A Retrospective Cohort. J Am Soc Nephrol. 2020 09; 31(9):2205-2221.
Score: 0.002
-
SARS-CoV-2 Is Not Detectable in the Vaginal Fluid of Women With Severe COVID-19 Infection. Clin Infect Dis. 2020 07 28; 71(15):813-817.
Score: 0.002
-
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19. N Engl J Med. 2020 04 23; 382(17):e38.
Score: 0.002
-
Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19. Clin Immunol. 2020 05; 214:108408.
Score: 0.002
-
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China. Clin Immunol. 2020 05; 214:108393.
Score: 0.002